Molina Healthcare, Inc. (NYSE:MOH) Shares Acquired by Royal Bank of Canada

Royal Bank of Canada increased its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 18.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 105,719 shares of the company's stock after acquiring an additional 16,360 shares during the period. Royal Bank of Canada owned approximately 0.18% of Molina Healthcare worth $30,770,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Wellington Management Group LLP lifted its stake in Molina Healthcare by 7.4% in the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after buying an additional 181,073 shares in the last quarter. FMR LLC lifted its stake in shares of Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after purchasing an additional 427,276 shares during the period. Geode Capital Management LLC lifted its stake in shares of Molina Healthcare by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock worth $417,144,000 after purchasing an additional 34,992 shares during the period. Invesco Ltd. lifted its stake in shares of Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after purchasing an additional 294,180 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Molina Healthcare by 15.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock worth $200,307,000 after purchasing an additional 91,229 shares during the period. Institutional investors and hedge funds own 98.50% of the company's stock.

Molina Healthcare Stock Up 0.0%

NYSE MOH traded up $0.05 during trading hours on Thursday, hitting $301.38. The company had a trading volume of 79,271 shares, compared to its average volume of 690,715. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $365.23. The company has a market capitalization of $16.34 billion, a price-to-earnings ratio of 14.75, a P/E/G ratio of 1.06 and a beta of 0.63. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. The firm's 50 day moving average is $323.92 and its 200 day moving average is $307.54.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The firm had revenue of $11.15 billion during the quarter, compared to the consensus estimate of $10.86 billion. During the same period in the prior year, the firm earned $5.73 EPS. The firm's quarterly revenue was up 12.2% compared to the same quarter last year. Sell-side analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on MOH. Robert W. Baird reissued a "neutral" rating and set a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Barclays increased their price target on Molina Healthcare from $339.00 to $362.00 and gave the stock an "equal weight" rating in a research note on Friday, April 25th. Mizuho increased their price target on Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. Finally, Baird R W lowered Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Nine research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Molina Healthcare currently has a consensus rating of "Hold" and a consensus price target of $365.38.

Insider Activity at Molina Healthcare

In other news, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the sale, the chief executive officer now directly owns 257,715 shares in the company, valued at $82,484,262.90. This trade represents a 25.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 89,169 shares of company stock worth $28,520,995. Corporate insiders own 1.10% of the company's stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.